Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

June 26, 2015

Primary Completion Date

July 3, 2017

Study Completion Date

February 22, 2019

Conditions
Small Cell Lung Cancer
Interventions
DRUG

Carboplatin

DRUG

Placebo

DRUG

Trilaciclib

DRUG

Etoposide

Trial Locations (40)

1121

Orszagos Koranyi Tbc es Pulmonologiai Intezet, XI. Tudobelosztaly, Budapest

2025

ARENSIA Exploratory Medicine Phase I Unit, The Institute of Oncology, Chisinau

5000

Hetenyi Geza Korhaz, Szolnok

8582

Veszprem Megyei Tudogyogyintezet, Farkasgyepű

12002

Consorcio Hospitalario Provincial, Castillón

14263

Roswell Park, Buffalo

18840

Guthrie Medical Group, PC, Sayre

19107

Thomas Jefferson University, Philadelphia

20817

Center For Cancer and Blood Disorders, Bethesda

27514

UNC - Lineberger Comprehensive Cancer Center, Chapel Hill

28009

Hgu Gregorio Maranon, Madrid

28040

Fundacion Jimenez Diaz, Madrid

29010

Hospital Regional Universitario HRU Carlos Haya Malaga, Málaga

29203

Gibbs Cancer Center, Spartanburg

29605

Greenville Health System, Greenville

30322

Emory University, Atlanta

30607

University Cancer and Blood Center, LLC, Athens

32778

Florida Cancer Specialists - North, Tavares

33401

Florida Cancer Specialists - East, West Palm Beach

33486

Boca Raton Regional Hospital - Lynn Cancer Institute, Boca Raton

33916

Florida Cancer Specialists - South, Fort Myers

35033

CHU de Rennes Hopital Pontchaillou, Rennes

37909

Tennessee Cancer Specialists, Knoxville

37920

Hanna Cancer Associates - University of Tennessee, Knoxville

40202

Norton Cancer Institute, Louisville

71913

Genesis Cancer Center, Hot Springs

72758

Highlands Oncology Group, Rogers

73117

Oklahoma University - Peggy and Charles Stephenson Cancer Center, Oklahoma City

75702

Texas Oncology, Tyler

80528

University of Colorado Health, Oncology Clinical Research Northern Region, Fort Collins

80909

Memorial Hospital - Univ. of Colorado Health, Colorado Springs

87106

University of New Mexico Comprehensive Cancer Center, Albuquerque

90603

The Oncology Institute of Hope and Innovation, Whittier

98684

Northwest Cancer Specialists, P.C., Vancouver

03756

Norris Cotton Cancer Center, Lebanon

0112

ARENSIA Exploratory Medicine LLC, Tbilisi

10-357

Samodzielny Publiczny ZespAA GruAicy i ChorAb PA¿uc, Olsztyn

87-100

Wojewodzki Szpital Zespolony im. L. Rydygiera, Torun

02-781

Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors
All Listed Sponsors
lead

G1 Therapeutics, Inc.

INDUSTRY